Signature Estate & Investment Advisors LLC Grows Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Signature Estate & Investment Advisors LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 8.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,901 shares of the financial services provider’s stock after purchasing an additional 669 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,296,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of IBB. Williams Financial LLC acquired a new stake in iShares Biotechnology ETF during the 2nd quarter valued at $867,000. PVG Asset Management Corp acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth $415,000. Avantax Advisory Services Inc. boosted its holdings in shares of iShares Biotechnology ETF by 38.4% during the first quarter. Avantax Advisory Services Inc. now owns 5,287 shares of the financial services provider’s stock worth $726,000 after purchasing an additional 1,466 shares during the last quarter. Concourse Financial Group Securities Inc. boosted its holdings in shares of iShares Biotechnology ETF by 22.4% during the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after purchasing an additional 120 shares during the last quarter. Finally, Raymond James & Associates boosted its holdings in shares of iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after purchasing an additional 7,931 shares during the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $133.38 on Friday. iShares Biotechnology ETF has a 52-week low of $116.70 and a 52-week high of $150.57. The stock’s fifty day simple moving average is $144.49 and its 200-day simple moving average is $141.59.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.